Trial intelligence / Profile preview

Behaviour and cognition in Alzheimer's disease patients treated with memantine

2005-004498-31Phase 4Active

Sponsor
Fondazione Santa Lucia IRCCS
Start
Mar 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of memantine in Alzheimer's disease (AD), sponsored by Fondazione Santa Lucia IRCCS. Primary endpoints: Behavioural outcomes and Cognitive outcomes. Started Mar 2006; status: active.

02

Drugs

memantine
03

Conditions

Alzheimer's disease (AD)

Beyond the preview

Go deeper on 2005-004498-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-004498-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call